PEAR Insider Trading Activity and SEC Form 4 Filings
PEAR insider trading summary
No open-market insider purchases or sales of Pear Therapeutics, Inc. (PEAR) have been reported on SEC Form 4 in the past 12 months.
Latest PEAR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 10, 2023 | 5AM Opportunities I, L.P. | 10% Owner | Sell | $1.5M (12,836,489 @ $0.12) |
| Apr 10, 2023 | Scott M Rocklage | 10% Owner | Sell | $1.5M (12,836,489 @ $0.12) |
| Apr 10, 2023 | 5AM Opportunities I, L.P. | 10% Owner | Sell | $64K (534,855 @ $0.12) |
| Apr 10, 2023 | 5AM Opportunities I (GP), LLC | 10% Owner | Sell | $64K (534,855 @ $0.12) |
| Apr 10, 2023 | 5AM Ventures IV, L.P. | 10% Owner | Sell | $1.5M (12,836,489 @ $0.12) |
| Apr 10, 2023 | John D Diekman | 10% Owner | Sell | $1.5M (12,836,489 @ $0.12) |
| Apr 10, 2023 | 5AM Co-Investors IV, L.P. | 10% Owner | Sell | $1.5M (12,836,489 @ $0.12) |
| Apr 10, 2023 | 5AM Opportunities I (GP), LLC | 10% Owner | Sell | $1.5M (12,836,489 @ $0.12) |
| Apr 10, 2023 | 5AM Partners IV, LLC | 10% Owner | Sell | $1.5M (12,836,489 @ $0.12) |
| Apr 10, 2023 | Andrew J. Schwab | 10% Owner | Sell | $1.5M (12,836,489 @ $0.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.